Work

Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-small Cell Lung Cancer

Year: 2008

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e3181874936

Authors: Gerold Bepler, K Eric Sommers, Alan Cantor, Xueli Li, Anupama Sharma, Charles Williams, Alberto Chiappori, Eric Haura, Scott Antonia, Tawee Tanvetyanon, George Simon, Coleman Obasaju, Lary A. Robinson

Institutions: University of South Florida, Moffitt Cancer Center, Eli Lilly (United States)

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, National Cancer Institute

Awards: Pharmacogenomics of Neoadjuvant Gemcitabine-Pemetrexed *, Enhancing neoadjuvant chemotherpay responses with targeted T cells, Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer

OpenAlex ID: W2083189837

FWCI: 10.11

Cites: 24

Cited by: 98

Related to: 10